Nitric oxide (NO) is a radical messenger molecule with many functions, including neurotransmission, vasodilation, and pathogen killing. NO is produced by the family of nitric oxide synthase (NOS) isoforms. Activated macrophages contribute in inflammatory process. Upon various stimuli (cytokines, growth factors, bacterial, fungi, parasite and viral infection, inflammation), macrophages express iNOS (NOS2) which in turn produce gaseous signaling molecule, NO. NO derived from macrophages can kill a variety of pathogens (viruses, bacteria, parasites, tumor cells), but NO can also be toxic for cells producing NO. Thus, macrophages producing a high-output of NO need to protect themselves from its toxic effects. This grant application proposes to search for and characterize proteins expressed inside macrophages that regulate NOS2 activity and thus protect host cells against NO cytotoxicity. A genetic screen has identified a novel NOS2-associated Protein 110 kD (NAP110) that interacts with NOS2. Physical complexes between NOS2 and NAP110 were detected in a variety of experimental conditions in vitro and in vivo. Preliminary Data also show that NAP110 binds to NOS2 and inhibits NOS2 activity in transfected cells.
The Specific Aims of this proposal are: (1) to analyze the domains of NOS2 and NAP110 that interact with each other; (2) to examine how NAP110 affects NOS2 function; (3) to localize NOS2 and NAP110 inside macrophages; (4) Does Chlamydia infection affect NOS2 and NAP110 localization? and (5) To examine the regulation NAP 110 gene at the transcription level. We will use various biochemical, molecular biology and cell biology techniques to study mechanisms of the interaction between NOS2 and NAP110 and their co-localization. They include; immunoprecipitation, immunoblotting, Northern blotting, two-hybrid yeast expression screen, in vitro translation and pull-down assay, transfection, genetic reporter assay and gel shift assay, and confocal immunofluorescense imaging analysis, differential and gradient centrifugation. This is a first report of a protein that interacts with NOS2 inside macrophages. The goal of these studies is to show how NOS2 and NAP110 interact with each other, and the consequences of this interaction. In particular, this application proposes to examine how NAP110 regulates NOS2 structure (homodimerization) and function (activity). These studies will increase our understanding of how NOS2 is regulated (negatively or positively) by NOS2-associated protein (s) and how macrophages and other cells that express NOS2 are protected against NO cytotoxicity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI047224-01
Application #
6087479
Study Section
Immunological Sciences Study Section (IMS)
Program Officer
Kraemer, Kristy A
Project Start
2000-04-15
Project End
2005-03-31
Budget Start
2000-04-15
Budget End
2001-03-31
Support Year
1
Fiscal Year
2000
Total Cost
$280,600
Indirect Cost
Name
Johns Hopkins University
Department
Pathology
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Ratovitski, Edward A (2011) ?Np63?/IRF6 interplay activates NOS2 transcription and induces autophagy upon tobacco exposure. Arch Biochem Biophys 506:208-15
Huang, Yiping; Ratovitski, Edward A (2010) Phosphorylated TP63 induces transcription of RPN13, leading to NOS2 protein degradation. J Biol Chem 285:41422-31
Huang, Yi-Ping; Kim, Yuriy; Li, Zhaobo et al. (2005) AEC-associated p63 mutations lead to alternative splicing/protein stabilization of p63 and modulation of Notch signaling. Cell Cycle 4:1440-7
Huang, Yi-Ping; Wu, Guojun; Guo, Zhongmin et al. (2004) Altered sumoylation of p63alpha contributes to the split-hand/foot malformation phenotype. Cell Cycle 3:1587-96
Fomenkov, Alexey; Zangen, Rachel; Huang, Yi-Ping et al. (2004) RACK1 and stratifin target DeltaNp63alpha for a proteasome degradation in head and neck squamous cell carcinoma cells upon DNA damage. Cell Cycle 3:1285-95
Wu, Guojun; Nomoto, Shuji; Hoque, Mohammad Obaidul et al. (2003) DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res 63:2351-7
Fomenkov, Alexey; Huang, Yi-Ping; Topaloglu, Ozlem et al. (2003) P63 alpha mutations lead to aberrant splicing of keratinocyte growth factor receptor in the Hay-Wells syndrome. J Biol Chem 278:23906-14
Ratovitski, E A; Patturajan, M; Hibi, K et al. (2001) p53 associates with and targets Delta Np63 into a protein degradation pathway. Proc Natl Acad Sci U S A 98:1817-22